Comparison of Dual-ISH (DISH) with Fluorescence In-Situ Hybridization (FISH) and Correlation with Immunohistochemical Findings for HER-2/Neu Status in Breast Carcinoma

被引：0
|
作者：
Wallander, M. L.
Layfield, L. J.
Tripp, S. R.
机构：
[1] ARUP Labs, Salt Lake City, UT USA
[2] Univ Missouri, Columbia, MO USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
341
引用
收藏
页码：87A / 87A
页数：1
相关论文
共 50 条
  • [1] Comparison of Dual-ISH (DISH) with Fluorescence In-Situ Hybridization (FISH) and Correlation with Immunohistochemical Findings for HER-2/Neu Status in Breast Carcinoma
    Wallander, M. L.
    Layfield, L. J.
    Tripp, S. R.
    LABORATORY INVESTIGATION, 2014, 94 : 87A - 87A
  • [2] Comparison of Dual-ISH (DISH) With Fluorescence In Situ Hybridization (FISH) and Correlation With Immunohistochemical Findings for HER2/Neu Status in Breast Carcinoma
    Layfield, Lester J.
    Wallander, Michelle L.
    Tripp, Sheryl R.
    Redpath, Stella
    Banks, Peter M.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (04) : 231 - 236
  • [3] Comparison of Fluorescence In Situ Hybridization (FISH) and Dual-ISH (DISH) in the Determination of HER2 Status in Breast Cancer
    Mansfield, Aaron S.
    Sukov, William R.
    Eckel-Passow, Jeanette E.
    Sakai, Yuta
    Walsh, Frank J.
    Lonzo, Melissa
    Wiktor, Anne E.
    Dogan, Ahmet
    Jenkins, Robert B.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (02) : 144 - 150
  • [4] Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (D-ISH) in the determination of HER2 status
    Mansfield, A. S.
    Sakai, Y.
    Walsh, F. J.
    Wiktor, A. E.
    Sukov, W. R.
    Dogan, A.
    Jenkins, R. B.
    CANCER RESEARCH, 2012, 72
  • [5] Comparison of immunohistochemical and fluorescence in situ hybridization assessment for topoisomerase IIalpha gene and HER-2/NEU status in breast carcinoma
    Neagu, M.
    Andrei, F.
    Butur, G.
    Diana, T.
    Georgescu, A.
    Ardeleanu, C.
    FEBS JOURNAL, 2008, 275 : 340 - 340
  • [6] Comparison of fluorescence in situ hybridization and immunohistochemical analysis for HER-2/neu detection in breast carcinoma.
    Li, Y
    Battaglia, T
    Davis, M
    Hankins, L
    Hagemeister, S
    Arthur, T
    Tawfik, O
    Persons, D
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 641 - 642
  • [7] HER2 status in lung adenocarcinoma: A comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations
    Yoshizawa, Akihiko
    Sumiyoshi, Shinji
    Sonobe, Makoto
    Kobayashi, Masashi
    Uehara, Takeshi
    Fujimoto, Masakazu
    Tsuruyama, Tatsuaki
    Date, Hiroshi
    Haga, Hironori
    LUNG CANCER, 2014, 85 (03) : 373 - 378
  • [8] HER-2/neu testing in breast carcinoma:: A combined immunohistochemical and fluorescence In situ hybridization approach
    Ridolfi, RL
    Jamehdor, MR
    Arber, JM
    MODERN PATHOLOGY, 2000, 13 (08) : 866 - 873
  • [9] Comparison of PathVysion and INFORM Fluorescence In Situ Hybridization Kits for Assessment of HER-2/neu Status in Breast Carcinoma
    Sanjay Kakar
    Nick Puangsuvan
    Jane M. Stevens
    Romualda Serenas
    George Mangan
    Shalini Sahai
    Michael L. Mihalov
    Molecular Diagnosis, 2000, 5 (3) : 193 - 197
  • [10] Comparison of PathVysion and INFORM fluorescence in situ hybridization kits for assessment of HER-2/neu status in breast carcinoma
    Kakar, S
    Puangsuvan, N
    Stevens, JM
    Serenas, R
    Mangan, G
    Sahai, S
    Mihalov, ML
    MOLECULAR DIAGNOSIS, 2000, 5 (03): : 193 - 197
12345